[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 54.158.83.210. Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Views 362
Citations 0
Observation
March 2015

In Vivo Cross-sectional Imaging of a Degrading Dexamethasone Intravitreal Implant That Became Attached to the Macula

Author Affiliations
  • 1Department of Ophthalmology, Seoul National University College of Medicine, Seoul National University Hospital, Seoul, Korea
  • 2Department of Ophthalmology, Seoul National University College of Medicine, Seoul National University Bundang Hospital, Seongnam, Korea
JAMA Ophthalmol. 2015;133(3):350-352. doi:10.1001/jamaophthalmol.2014.5153

Dexamethasone intravitreal implant (Ozurdex) is a rod-shaped biodegradable implant composed of polylactic co-glycolic acid (PLGA) and 0.7 mg of dexamethasone. It has been shown to be effective for macular edema due to uveitis, retinal vein occlusion, or diabetic retinopathy.1,2

First Page Preview View Large
First page PDF preview
First page PDF preview
×